Frequency of positive purified protein derivative test in those infected with human immunodeficiency virus

Archives of Iranian Medicine

Volumn 9, Issue 3, 2006, Pages 218-221

  Mohraz, Minoo ^a   Ramezani, Amitis ^b   Gachkar, Latif ^c   Velayati, Ali Akbar ^d  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b PASTEUR INSTITUTE OF IRAN   (Iran)

^c SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Human immunodeficiency virus (HIV); Isoniazid preventive therapy (IPT); Purified protein derivative (PPD); Tuberculosis

Indexed keywords

BCG VACCINE; CD4 ANTIGEN; ISONIAZID; TUBERCULIN;

ADULT; ARTICLE; BLOOD TRANSFUSION; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CORRELATION ANALYSIS; DEMOGRAPHY; DIALYSIS; DISEASE ASSOCIATION; DISEASE TRANSMISSION; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ABUSE; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; NEEDLESTICK INJURY; RISK FACTOR; SEX DIFFERENCE; SEXUAL TRANSMISSION; SKIN TEST; TATTOOING; TUBERCULIN TEST; TUBERCULOSIS;

ADOLESCENT; ADULT; FEMALE; HIV; HIV INFECTIONS; HUMANS; INCIDENCE; IRAN; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TUBERCULIN TEST; TUBERCULOSIS;

EID: 33746432970     PISSN: 10292977     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Mandalakas AM, Guay L, Musoke P, Carroll-Pankhurst C, Olness KN. Human immunodeficiency virus status and delayed-type hypersensitivity skin testing in Ugandan children. Pediatrics. 1999; 103: E21.
2. Johnson MP, Coberly JS, Clermont HC, Chaisson RE, Davis HL, Losikoff P, et al. Tuberculin skin test reactivity among adults infected with human immunodeficiency virus. J Infect Dis. 1992; 166: 194-198.
3. Portu JJ, Aldamiz-Etxebarria M, Agude JM, Arevalo JM, Almoroz MJ, Ayesa C. Tuberculin skin testing in intravenous drug users: difference between HIV-seropositive and HIV-seronegative subjects. Addict Biol. 2002; 7: 235-241.
4. Chan KC, Tang HW, Wong K. Prevalence of purified protein derivative positivity in human immunodeficiency virus-infected individuals in Hong Kong. Chin Med J (Engl). 2002; 115: 1091-1092.
5. Gourevitch MN, Hartel D, Schoenbaum EE, Klein RS. Lack of association of induration's size with HIV infection among drug users reacting to tuberculin. Am J Respir Crit Care Med. 1996; 154: 1029-1033.
6. Markowitz N, Hansen NJ, Wilcosky TC, Hopewell PC, Glassroth J, Kvale PA, et al. Tuberculin and anergy testing in HIV-positive and HIV-negative persons. Pulmonary Complications of HIV Infection Study Group. Ann Intern Med. 1993; 119: 185-193.
7. Garcia-Garcia ML, Valdespino-Gomez JL, Garcia-Sancho C, Mayar-Maya ME, Palacios-Martinez M, Balandrano-Campos S, et al. Underestimation of Mycobacterium tuberculosis infection in HIV-infected subjects using reactivity to tuberculin and anergy panel. Int J Epidemiol. 2000; 29: 369-375.
8. Graham NM, Nelson KE, Solomon L, Bonds M, Rizzo RT, Scavotto J, et al. Prevalence of tuberculin positivity and skin test anergy in HIV-seropositive and -seronegative intravenous drug users. JAMA. 1992; 267: 369-373.